The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
暂无分享,去创建一个
Arnold J. Levine | Martin Scheffner | A. Levine | M. Scheffner | P. Howley | J. Huibregtse | B. Werness | Jon M. Huibregtse | Peter M. Howley | Bruce A. Werness
[1] A Ciechanover,et al. How are substrates recognized by the ubiquitin-mediated proteolytic system? , 1989, Trends in biochemical sciences.
[2] E. Villiers. Heterogeneity of the human papillomavirus group. , 1989 .
[3] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[4] D. Givol,et al. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. , 1985, The EMBO journal.
[5] M. Ewen,et al. An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 , 1989, Cell.
[6] Erica S. Johnson,et al. Cis-trans recognition and subunit-specific degradation of short-lived proteins , 1990, Nature.
[7] Wolfgang Mayer,et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.
[8] Wen-Hwa Lee,et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.
[9] D. Pim,et al. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. , 1986, European journal of biochemistry.
[10] R. Schlegel,et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.
[11] H. Ruley. Transforming collaborations between ras and nuclear oncogenes. , 1990, Cancer cells.
[12] D. Lowy,et al. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.
[13] M. Oren,et al. Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Levine,et al. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.
[15] K. Yoshiike,et al. Transformation of rat 3Y1 cells by human papillomavirus type‐18 DNA , 1988, International journal of cancer.
[16] S. Benchimol,et al. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. , 1988, Oncogene.
[17] K. Münger,et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.
[18] D. Pim,et al. Comparison of the in vitro transforming activities of human papillomavirus types. , 1988, The EMBO journal.
[19] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[20] H. Hausen,et al. The Role of Papillomaviruses in Human Anogenital Cancer , 1987 .
[21] S. Grossman,et al. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells , 1989, Journal of virology.
[22] D. Lowy,et al. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. , 1988, Oncogene research.
[23] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[24] A. Levine,et al. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.
[25] P. Gruss,et al. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.
[26] S. Fields,et al. Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.
[27] J. Jenkins,et al. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.
[28] T. Smith,et al. Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins , 1988, Journal of virology.
[29] A. Haas,et al. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. , 1985, The Journal of biological chemistry.
[30] K. Münger,et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.
[31] J. Minna,et al. p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.
[32] A. Bernstein,et al. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus , 1985, Nature.
[33] A. Levine,et al. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.
[34] Stephen H. Friend,et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.
[35] B. Vogelstein,et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.
[36] A. Levine,et al. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.
[37] T. Kanda,et al. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7 , 1989, Journal of virology.
[38] D. Lane,et al. T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.
[39] E. Appella,et al. Wild type human p53 is antiproliferative in SV40-transformed hamster cells. , 1990, Oncogene.
[40] E. Harlow,et al. Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.
[41] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[42] R. Schlegel,et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.
[43] V. Rotter,et al. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene , 1984, Cell.
[44] E. Androphy,et al. Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. , 1990, The EMBO journal.
[45] Rotter,et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. , 1988, Oncogene.
[46] T. Noda,et al. Identification of a transforming gene of human papillomavirus type 16 , 1989, Journal of virology.
[47] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[48] T. Kanda,et al. Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. , 1988, Virology.
[49] V. Rotter,et al. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.
[50] F. Wettstein,et al. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[52] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.
[53] S. Grossman,et al. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18 , 1988, Journal of virology.
[54] G. Lozano,et al. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.